Biocon's shares surged over 7% on January 14, 2025, after HSBC upgraded its rating to 'Buy' with a target price of ₹430, citing an expected operational turnaround and key biosimilar launches. Other ...

Shares of Biocon soared over 4 percent on January 13 after the US Food and Drug Administration cleared arm Biocon Biologics' insulin facility in Malaysia, putting an end to a major regulatory ...

The regulator found that Goldman Sachs’ acquisition of optionally convertible debentures (OCDs) in Biocon, which would have translated to a 3.81 per cent stake in the company on a fully diluted ...

Kiran Mazumdar-Shaw, Chairperson of major drugmaker Biocon Ltd., urged the government to eliminate tax on drugs for cancer treatment and for chronic and rare diseases, ahead of the budget 2025 ...

Biotechnology company Biocon Ltd stated on Thursday (January 2) that its wholly owned subsidiary, Biocon Pharma Ltd, has acquired permission from the National Medical Products Administration (NMPA ...

Founded in 2022, Bengaluru-based Fermbox Bio uses precision fermentation and synthetic biology to programme microorganisms and produce bio-based enzymes and technologies to manufacture biofuels ...

Biocon Ltd share price was up by 0.14% from the previous closing price of ₹393.15. Who are peers of Biocon Ltd? The peers of Biocon Ltd are Sun Pharmaceuticals Industries Ltd, Divis Laboratories ...

Shares of Biocon Ltd climbed 7 per cent in Tuesday's trade, with the nearing its September 2024 high of Rs 395.65, after HSBC upgraded the stock to 'Buy' from 'Reduce' earlier. The foreign ...

A collection of the most-viewed Moneycontrol videos. Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting ...

Biocon Ltd has hired more top executives in its generics business, Maninder Kapoor Puri, head of human resources said. “As Biocon's generics business grows in key markets and secures approvals ...

The stock has gained 9.66% in the last month, 7.99% over the past six months, and an impressive 37.98% in the last year.

Kiran Mazumdar Shaw, chairperson, Biocon and Biocon Biologics said that the sector’s impressive growth trajectory, with pharmaceutical exports crossing $2.3 billion in July 2024, highlights its ...